Singapore- Axsome Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for the management...
GlaxoSmithKline (GSK) has announced the appointment of Kevin Sin as Senior Vice President and Head of Worldwide Business...
Singapore- Procter & Gamble has confirmed that it has signed a deal to acquire the Consumer Health business of ...
Singapore- Ra Pharmaceuticals, a clinical stage biopharmaceutical company focusing on the development of next-generation...
Singapore- Johnson & Johnson will implement a new pricing and dosage scheme for cancer med IMBRUVICA (ibrutinib) con...
Mundipharma is partnering with Caris Life Sciences, a leading US biotechnology company, to provide the exclusive sales, ...
Novartis has announced a five-year commitment to the fight against malaria in conjunction with the 7th Multilateral Init...
Sartorius Stedim Biotech and Penn State University (PSU) have entered into a collaborative partnership to advance multid...
GE Healthcare is launching a ready-to-run factory-in-a-box to speed up the production of viral vector based therapeutics...
Shire, a leading global biotechnology company focused on rare diseases is selling its oncology business to French drugma...
Singapore - In a study of more than 15,000 girls and their mothers — all Kaiser Permanente members in Norther...
Singapore – Nine major Italian federations representing sectors from fashion to healthcare and technology, arrived...
A group of scientists at the University of Bath has created a non-invasive adhesive patch that promises the measure...
Merck, a leading science and technology company has announced a partnership with Oxford University’s Jenner I...
Singapore- Sanofi is investing €350M (CAD $500M) to construct a new state-of-art vaccine manufacturing facilit...
Mylan and Biocon have agreed to accelerate introduction of adalimumab biosimilar in Europe through Mylan’s in-lice...
Singapore- Boston Therapeutics inks a non-binding letter of intent with Medical Technology Associates to acqui...
Singapore- Woburn, MA-based Abpro Therapeutics (ABP) has filed a preliminary prospectus for a $69M I...